Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

2,066.00p

Buy

2,068.00p

arrow-down-14.00p (-0.67%)

Prices updated at 16 May 2025, 17:40 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

Most recent dividend payment

0.372
Cash Dividend
20 Mar 2025
26 Feb 2025
21 Mar 2025
01 May 2025

Total dividend yield

Created with Highcharts 7.2.2Total yield (%)Total yield (%)2021202220232024202502.557.51012.5

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20250.3721-
20240.61410.27
20230.49410.17
20220.42000.02
20210.37700.13
20200.36220.07
20190.34000.25
20180.25400.05
20170.30500.04
20160.22920.24

Total dividend yield data table

Dividend yield (%)Buyback yield (%)
20253.150.68
20243.08-
20232.76-
20222.717.28
20211.70-
20201.44-
20191.71-
20181.48-
20172.24-
20161.21-

Dividend per share

Created with Highcharts 7.2.2Dividend per shareDividend per share2021202220232024202500.20.40.60.8

% of earnings paid to shareholders

Created with Highcharts 7.2.2Payout ratio (%)Payout ratio (%)202120222023202420250255075100

Dividend per share data table

YearDividend per share
20250.3721
20240.6141
20230.4941
20220.4200
20210.3770
20200.3622
20190.3400
20180.2540
20170.3050
20160.2292

% of earnings paid to shareholders data table

YearPayout ratio (%)
202548.91
202456.82
202382.79
202234.76
202124.89
202022.27
201925.75
2018-
201747.60
201637.95
Latest Financial Report as of 16 May 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.